Q1 2025 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2025-05-15 · accession 0001420506-25-001188
$100.9M
Reported value
7
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131M109 | GH | GUARDANT HEALTH INC | $29.6M | 29.3% | 694,047 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $29.5M | 29.2% | 208,494 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $15.9M | 15.8% | 2,145,145 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $12.9M | 12.7% | 724,014 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $6.5M | 6.47% | 4,697,785 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $4.1M | 4.09% | 1,175,400 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $2.4M | 2.40% | 372,175 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.